@dansfera: This financial instrument floating around the biotech world is seriously interesting! Forget just getting faster FDA review—we're talking about the Priority Review Voucher. Once earned, this isn't just a stamp; it's a *sellable* asset other companies can buy. A game-changer for company valuations! #FDAVoucher #BiotechInvesting #PharmaFinance #DrugReview #SellableAsset

dansfera

Open In TikTok:

Region: US

Monday 08 December 2025 23:05:44 GMT